Abstract
A study was conducted to elucidate pharmacists' evaluation of panic disorder medications for recommendation to physicians. A mail questionnaire was used to collect the data from a nationally representative, geographically stratified random sample of 1,742 community pharmacists. Common factor analysis was used to analyze the interrelationships among 31 variables and to explain them in terms of their common underlying dimensions (factors). Seven factors explained 60.7% of the variance. The factor relating to efficacy considerations (e.g., documented clinical efficacy and obvious therapeutic response) explained 24.2% of the variance and was found to be important in pharmacists' recommendation of panic disorder drug products.